Compare LKFT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LKFT | PLSE |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Belgium | United States |
| Employees | 452 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2015 | 2015 |
| Metric | LKFT | PLSE |
|---|---|---|
| Price | $30.58 | $28.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 141.3K | ★ 342.7K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.00 | $12.56 |
| 52 Week High | $30.50 | $31.00 |
| Indicator | LKFT | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 78.93 | 55.63 |
| Support Level | N/A | $23.94 |
| Resistance Level | N/A | $27.82 |
| Average True Range (ATR) | 0.62 | 1.76 |
| MACD | 0.17 | 0.12 |
| Stochastic Oscillator | 93.36 | 48.84 |
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.